[1] Falkinham, J. O., III (2002): Nontuberculous mycobacteria in the environment, Clin.Chest Med. 23 [3], Seite 529-551. URL: PM:12370991 [2] Rastogi, N.; Legrand, E. und Sola, C. (2001): The mycobacteria: an introduction to nomenclature and pathogenesis, Rev.Sci.Tech. 20 [1], Seite 21-54. URL: PM:11288513 [3] Koch, R. (1882): [4] Ferlinz, R. (21995): [5] Ehrlich, P (1882): Zur Färbung der Tuberkelbakterien, Deutsche Med Wochenschr 8, Seite 269-270. [6] Ziehl, F (1882): Zur Färbung des Tuberkelbacillus, Deutsche Med Wochenschr 33, Seite 451. [7] Neelsen, A (1883): Ein casuistischer Beitrag zu Lehre von der Tuberkulose, Centralblatt für die medizinischen Wissenschaften 28, Seite 497-501. [8] Falkow, S. (1988): Molecular Koch's postulates applied to microbial pathogenicity, Rev.Infect.Dis. 10 Suppl 2, Seite S274-S276. URL: PM:3055197 [9] Bardarov, S.; Bardarov Jr S Jr; Pavelka, Jr MS, Jr.; Sambandamurthy, V.; Larsen, M.; Tufariello, J.; Chan, J.; Hatfull, G. und Jacobs, Jr WR, Jr. (2002): Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis, Microbiology 148 [Pt 10], Seite 3007-3017. URL: PM:12368434 [10] Bottiger, M.; Romanus, V.; de Verdier, C. und Boman, G. (1982): Osteitis and other complications caused by generalized BCG-itis. Experiences in Sweden, Acta Paediatr.Scand. 71 [3], Seite 471-478. URL: PM:6753476 [11] Fine, P. E. (1995): Variation in protection by BCG: implications of and for heterologous immunity, Lancet 346 [8986], Seite 1339-1345. URL: PM:7475776 [12] Kaufmann, S. H. und Hess, J. (1997): Rational design of antituberculosis vaccines: impact of antigen display and vaccine localization, Biologicals 25 [2], Seite 169-173. URL: PM:9236047 [13] Manabe, Y. C. und Bishai, W. R. (2000): Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting, Nat.Med. 6 [12], Seite 1327-1329. URL: PM:11100115 [14] Armstrong, J. A. und Hart, P. D. (1975): Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival, J.Exp.Med. 142 [1], Seite 1-16. URL: PM:807671 [15] Russell, D. G.; Dant, J. und Sturgill-Koszycki, S. (1996): Mycobacterium avium- and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma, J.Immunol. 156 [12], Seite 4764-4773. URL: PM:8648123 [16] Harth, G. und Horwitz, M. A. (1999): An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets, J.Exp.Med. 189 [9], Seite 1425-1436. URL: PM:10224282 [17] Ferrari, G.; Langen, H.; Naito, M. und Pieters, J. (1999): A coat protein on phagosomes involved in the intracellular survival of mycobacteria, Cell 97 [4], Seite 435-447. URL: PM:10338208 [18] Nathan, C. und Shiloh, M. U. (2000): Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens, Proc.Natl.Acad.Sci.U.S.A 97 [16], Seite 8841-8848. URL: PM:10922044 [19] Schaible, U. E.; Collins, H. L.; Priem, F. und Kaufmann, S. H. (2002): Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis, J.Exp.Med. 196 [11], Seite 1507-1513. URL: PM:12461085 [20] Kaufmann, S. H. (2001): How can immunology contribute to the control of tuberculosis?, Nat.Rev.Immunol. 1 [1], Seite 20-30. URL: PM:11905811 [21] Kaufmann, S. H. (2002): Protection against tuberculosis: cytokines, T cells, and macrophages, Ann.Rheum.Dis. 61 Suppl 2, Seite ii54-ii58. URL: PM:12379623 [22] Stenger, S.; Rosat, J. P.; Bloom, B. R.; Krensky, A. M. und Modlin, R. L. (1999): Granulysin: a lethal weapon of cytolytic T cells, Immunol.Today 20 [9], Seite 390-394. URL: PM:10462738 [23] Flynn, J. L. und Chan, J. (2001): Immunology of tuberculosis, Annu.Rev.Immunol. 19, Seite 93-129. URL: PM:11244032 [24] Brennan, P. J. und Nikaido, H. (1995): The envelope of mycobacteria, Annu.Rev.Biochem. 64, Seite 29-63. URL: PM:7574484 [25] Trias, J.; Jarlier, V. und Benz, R. (1992): Porins in the cell wall of mycobacteria, Science 258 [5087], Seite 1479-1481. URL: PM:1279810 [26] Heinz, C.; Roth, E. und Niederweis, M. (2003): Purification of porins from Mycobacterium smegmatis, Methods Mol.Biol. 228, Seite 139-150. URL: PM:12824550 [27] Niederweis, M. (2003): Mycobacterial porins--new channel proteins in unique outer membranes, Mol.Microbiol. 49 [5], Seite 1167-1177. URL: PM:12940978 [28] Trias, J. und Benz, R. (1994): Permeability of the cell wall of Mycobacterium smegmatis, Mol.Microbiol. 14 [2], Seite 283-290. URL: PM:7830572 [29] Navarre, W. W. und Schneewind, O. (1999): Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope, Microbiol.Mol.Biol.Rev. 63 [1], Seite 174-229. URL: PM:10066836 [30] Miller, B. H. und Shinnick, T. M. (2000): Evaluation of Mycobacterium tuberculosis genes involved in resistance to killing by human macrophages, Infect.Immun. 68 [1], Seite 387-390. URL: PM:10603413 [31] Lustgarten, S. (1884): Ueber spezifische Bacillen in syphilitischen Krankheitsprodukten, Wiener medizinische Wochenschrift [47], Seite 1-1. [32] Alvarez und Tavel (1885): Recherches sur le bacille de Lustgarten, Arch.Physiol.Normal Pathol., Seite 303-321. [33] O'Toole, G.; Kaplan, H. B. und Kolter, R. (2000): Biofilm formation as microbial development, Annu.Rev.Microbiol. 54, Seite 49-79. URL: PM:11018124 [34] Bardouniotis, E.; Ceri, H. und Olson, M. E. (2003): Biofilm formation and biocide susceptibility testing of Mycobacterium fortuitum and Mycobacterium marinum, Curr.Microbiol. 46 [1], Seite 28-32. URL: PM:12432460 [35] Teng, R. und Dick, T. (2003): Isoniazid resistance of exponentially growing Mycobacterium smegmatis biofilm culture, FEMS Microbiol.Lett. 227 [2], Seite 171-174. URL: PM:14592705 [36] Davies, D. (2003): Understanding biofilm resistance to antibacterial agents, Nat.Rev.Drug Discov. 2 [2], Seite 114-122. URL: PM:12563302 [37] Wallace, R. J., Jr.; Nash, D. R.; Tsukamura, M.; Blacklock, Z. M. und Silcox, V. A. (1988): Human disease due to Mycobacterium smegmatis, J.Infect.Dis. 158 [1], Seite 52-59. URL: PM:3392420 [38] Cain, B. D.; Norton, P. J.; Eubanks, W.; Nick, H. S. und Allen, C. M. (1993): Amplification of the bacA gene confers bacitracin resistance to Escherichia coli, J.Bacteriol. 175 [12], Seite 3784-3789. URL: PM:8389741 [39] Chalker, A. F.; Ingraham, K. A.; Lunsford, R. D.; Bryant, A. P.; Bryant, J.; Wallis, N. G.; Broskey, J. P.; Pearson, S. C. und Holmes, D. J. (2000): The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulence, Microbiology 146 ( Pt 7), Seite 1547-1553. URL: PM:10878119 [40] Snapper, S. B.; Melton, R. E.; Mustafa, S.; Kieser, T. und Jacobs, W. R., Jr. (1990): Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis, Mol.Microbiol. 4 [11], Seite 1911-1919. URL: PM:2082148 [41] Schaible, U. E. und Kaufmann, S. H. (2002): Studying trafficking of intracellular pathogens in antigen-presenting cells, Methods in Microbiology 31, Seite 343-360. [42] Klose, J. und Kobalz, U. (1995): Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome, Electrophoresis 16 [6], Seite 1034-1059. URL: PM:7498127 [43] Jungblut, P. R. und Seifert, R. (1990): Analysis by high-resolution two-dimensional electrophoresis of differentiation-dependent alterations in cytosolic protein pattern of HL-60 leukemic cells, J.Biochem.Biophys.Methods 21 [1], Seite 47-58. URL: PM:1698848 [44] Doherty, N. S.; Littman, B. H.; Reilly, K.; Swindell, A. C.; Buss, J. M. und Anderson, N. L. (1998): Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis, Electrophoresis 19 [2], Seite 355-363. URL: PM:9548303 [45] Aksu, S.; Scheler, C.; Focks, N.; Leenders, F.; Theuring, F.; Salnikow, J. und Jungblut, P. R. (2002): An iterative calibration method with prediction of post-translational modifications for the construction of a two-dimensional electrophoresis database of mouse mammary gland proteins, Proteomics. 2 [10], Seite 1452-1463. URL: PM:12422362 [46] Henzel, W. J.; Billeci, T. M.; Stults, J. T.; Wong, S. C.; Grimley, C. und Watanabe, C. (1993): Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases, Proc.Natl.Acad.Sci.U.S.A 90 [11], Seite 5011-5015. URL: PM:8506346 [47] James, P.; Quadroni, M.; Carafoli, E. und Gonnet, G. (1993): Protein identification by mass profile fingerprinting, Biochem.Biophys.Res.Commun. 195 [1], Seite 58-64. URL: PM:8363627 [48] Mann, M.; Hojrup, P. und Roepstorff, P. (1993): Use of mass spectrometric molecular weight information to identify proteins in sequence databases, Biol.Mass Spectrom. 22 [6], Seite 338-345. URL: PM:8329463 [49] Mann, M. und Wilm, M. (1994): Error-tolerant identification of peptides in sequence databases by peptide sequence tags, Anal.Chem. 66 [24], Seite 4390-4399. URL: PM:7847635 [50] Peng, J. und Gygi, S. P. (2001): Proteomics: the move to mixtures, J.Mass Spectrom. 36 [10], Seite 1083-1091. URL: PM:11747101 [51] Jungblut, P. R.; Schaible, U. E.; Mollenkopf, H. J.; Zimny-Arndt, U.; Raupach, B.; Mattow, J.; Halada, P.; Lamer, S.; Hagens, K. und Kaufmann, S. H. (1999): Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens, Mol.Microbiol. 33 [6], Seite 1103-1117. URL: PM:10510226 [52] Mollenkopf, H. J.; Mattow, J.; Schaible, U. E.; Grode, L.; Kaufmann, S. H. und Jungblut, P. R. (2002): Mycobacterial proteomes, Methods Enzymol. 358, Seite 242-256. URL: PM:12474391 [53] Mattow, J.; Jungblut, P. R.; Schaible, U. E.; Mollenkopf, H. J.; Lamer, S.; Zimny-Arndt, U.; Hagens, K.; Muller, E. C. und Kaufmann, S. H. (2001): Identification of proteins from Mycobacterium tuberculosis missing in attenuated Mycobacterium bovis BCG strains, Electrophoresis 22 [14], Seite 2936-2946. URL: PM:11565788 [54] Muller, E. C.; Schumann, M.; Rickers, A.; Bommert, K.; Wittmann-Liebold, B. und Otto, A. (1999): Study of Burkitt lymphoma cell line proteins by high resolution two-dimensional gel electrophoresis and nanoelectrospray mass spectrometry, Electrophoresis 20 [2], Seite 320-330. URL: PM:10197439 [55] Wilm, M.; Neubauer, G. und Mann, M. (1996): Parent ion scans of unseparated peptide mixtures, Anal.Chem. 68 [3], Seite 527-533. URL: PM:8712361 [56] Perkins, D. N.; Pappin, D. J.; Creasy, D. M. und Cottrell, J. S. (1999): Probability-based protein identification by searching sequence databases using mass spectrometry data, Electrophoresis 20 [18], Seite 3551-3567. URL: PM:10612281 [57] Rolph, M. S.; Raupach, B.; Kobernick, H. H.; Collins, H. L.; Perarnau, B.; Lemonnier, F. A. und Kaufmann, S. H. (2001): MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis, Eur.J.Immunol. 31 [6], Seite 1944-1949. URL: PM:11433392 [58] Pavelka, M. S., Jr. und Jacobs, W. R., Jr. (1999): Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guerin, and Mycobacterium tuberculosis H37Rv by allelic exchange, J.Bacteriol. 181 [16], Seite 4780-4789. URL: PM:10438745 [59] Collins, L. und Franzblau, S. G. (1997): Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium, Antimicrob.Agents Chemother. 41 [5], Seite 1004-1009. URL: PM:9145860 [60] Recht, J. und Kolter, R. (2001): Glycopeptidolipid acetylation affects sliding motility and biofilm formation in Mycobacterium smegmatis, J.Bacteriol. 183 [19], Seite 5718-5724. URL: PM:11544235 [61] Soto, C. Y.; Andreu, N.; Gibert, I. und Luquin, M. (2002): Simple and rapid differentiation of Mycobacterium tuberculosis H37Ra from M. tuberculosis clinical isolates through two cytochemical tests using neutral red and nile blue stains, J.Clin.Microbiol. 40 [8], Seite 3021-3024. URL: PM:12149369 [62] Ryll, R.; Kumazawa, Y. und Yano, I. (2001): Immunological properties of trehalose dimycolate (cord factor) and other mycolic acid-containing glycolipids--a review, Microbiol.Immunol. 45 [12], Seite 801-811. URL: PM:11838897 [63] Byrd, T. F.; Green, G. M.; Fowlston, S. E. und Lyons, C. R. (1998): Differential growth characteristics and streptomycin susceptibility of virulent and avirulent Mycobacterium tuberculosis strains in a novel fibroblast-mycobacterium microcolony assay, Infect.Immun. 66 [11], Seite 5132-5139. URL: PM:9784514 [64] Quinn, F. D.; Birkness K.A. und King J.K. (2002): Alpha-Crystallin as a Potential Marker of Mycobacterium tuberculosis Latency, ASM News. [65] Sherman, D. R.; Voskuil, M.; Schnappinger, D.; Liao, R.; Harrell, M. I. und Schoolnik, G. K. (2001): Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin, Proc.Natl.Acad.Sci.U.S.A 98 [13], Seite 7534-7539. URL: PM:11416222 [66] Kremer, L.; Dover, L. G.; Morbidoni, H. R.; Vilcheze, C.; Maughan, W. N.; Baulard, A.; Tu, S. C.; Honore, N.; Deretic, V.; Sacchettini, J. C.; Locht, C.; Jacobs, W. R., Jr. und Besra, G. S. (2003): Inhibition of InhA activity, but not KasA activity, induces formation of a KasA-containing complex in mycobacteria, J.Biol.Chem. 278 [23], Seite 20547-20554. URL: PM:12654922 [67] Slayden, R. A. und Barry, C. E., III (2002): The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis, Tuberculosis.(Edinb.) 82 [4-5], Seite 149-160. URL: PM:12464486 [68] Mombaerts, P.; Iacomini, J.; Johnson, R. S.; Herrup, K.; Tonegawa, S. und Papaioannou, V. E. (1992): RAG-1-deficient mice have no mature B and T lymphocytes, Cell 68 [5], Seite 869-877. URL: PM:1547488 [69] Lee, R. E.; Brennan, P. J. und Besra, G. S. (1996): Mycobacterium tuberculosis cell envelope, Curr.Top.Microbiol.Immunol. 215, Seite 1-27. URL: PM:8791707 [70] Mdluli, K.; Slayden, R. A.; Zhu, Y.; Ramaswamy, S.; Pan, X.; Mead, D.; Crane, D. D.; Musser, J. M. und Barry, C. E., III (1998): Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid, Science 280 [5369], Seite 1607-1610. URL: PM:9616124 [71] Lee, A. S.; Lim, I. H.; Tang, L. L.; Telenti, A. und Wong, S. Y. (1999): Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore, Antimicrob.Agents Chemother. 43 [8], Seite 2087-2089. URL: PM:10428945 [72] Piatek, A. S.; Telenti, A.; Murray, M. R.; El Hajj, H.; Jacobs, W. R., Jr.; Kramer, F. R. und Alland, D. (2000): Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing, Antimicrob.Agents Chemother. 44 [1], Seite 103-110. URL: PM:10602730 [73] Bloch, K. (1977): Control mechanisms for fatty acid synthesis in Mycobacterium smegmatis, Adv.Enzymol.Relat Areas Mol.Biol. 45, Seite 1-84. URL: PM:21523 [74] Kremer, L.; Douglas, J. D.; Baulard, A. R.; Morehouse, C.; Guy, M. R.; Alland, D.; Dover, L. G.; Lakey, J. H.; Jacobs, W. R., Jr.; Brennan, P. J.; Minnikin, D. E. und Besra, G. S. (2000): Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis, J.Biol.Chem. 275 [22], Seite 16857-16864. URL: PM:10747933 [75] Kremer, L.; Dover, L. G.; Carrere, S.; Nampoothiri, K. M.; Lesjean, S.; Brown, A. K.; Brennan, P. J.; Minnikin, D. E.; Locht, C. und Besra, G. S. (2002): Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis, Biochem.J. 364 [Pt 2], Seite 423-430. URL: PM:12023885 [76] Russell, D. G. (2003): Phagosomes, fatty acids and tuberculosis, Nat.Cell Biol. 5 [9], Seite 776-778. URL: PM:12951608 [77] Fratti, R. A.; Vergne, I.; Chua, J.; Skidmore, J. und Deretic, V. (2000): Regulators of membrane trafficking and Mycobacterium tuberculosis phagosome maturation block, Electrophoresis 21 [16], Seite 3378-3385. URL: PM:11079558 [78] Fischer, K.; Chatterjee, D.; Torrelles, J.; Brennan, P. J.; Kaufmann, S. H. und Schaible, U. E. (2001): Mycobacterial lysocardiolipin is exported from phagosomes upon cleavage of cardiolipin by a macrophage-derived lysosomal phospholipase A2, J.Immunol. 167 [4], Seite 2187-2192. URL: PM:11490004 [79] Lawrence, J. R.; Korber, D. R.; Hoyle, B. D.; Costerton, J. W. und Caldwell, D. E. (1991): Optical sectioning of microbial biofilms, J.Bacteriol. 173 [20], Seite 6558-6567. URL: PM:1917879 [80] Lawrence, J. R. und Neu, T. R. (1999): Confocal laser scanning microscopy for analysis of microbial biofilms, Methods Enzymol. 310, Seite 131-144. URL: PM:10547787 [81] Davies, D. G.; Parsek, M. R.; Pearson, J. P.; Iglewski, B. H.; Costerton, J. W. und Greenberg, E. P. (1998): The involvement of cell-to-cell signals in the development of a bacterial biofilm, Science 280 [5361], Seite 295-298. URL: PM:9535661 [82] Martinelli, D.; Bachofen, R. und Brandl, H. (2002): Effect of medium composition, flow rate, and signaling compounds on the formation of soluble extracellular materials by biofilms of Chromobacterium violaceum, Appl.Microbiol.Biotechnol. 59 [2-3], Seite 278-283. URL: PM:12111158 [83] Huber, B.; Riedel, K.; Kothe, M.; Givskov, M.; Molin, S. und Eberl, L. (2002): Genetic analysis of functions involved in the late stages of biofilm development in Burkholderia cepacia H111, Mol.Microbiol. 46 [2], Seite 411-426. URL: PM:12406218 [84] Brown, M. R.; Allison, D. G. und Gilbert, P. (1988): Resistance of bacterial biofilms to antibiotics: a growth-rate related effect?, J.Antimicrob.Chemother. 22 [6], Seite 777-780. URL: PM:3072331 [85] Stewart, P. S. (2002): Mechanisms of antibiotic resistance in bacterial biofilms, Int.J.Med.Microbiol. 292 [2], Seite 107-113. URL: PM:12195733 [86] Recht, J.; Martinez, A.; Torello, S. und Kolter, R. (2000): Genetic analysis of sliding motility in Mycobacterium smegmatis, J.Bacteriol. 182 [15], Seite 4348-4351. URL: PM:10894747 [87] Brinton, L. A.; Li, J. Y.; Rong, S. D.; Huang, S.; Xiao, B. S.; Shi, B. G.; Zhu, Z. J.; Schiffman, M. H. und Dawsey, S. (1991): Risk factors for penile cancer: results from a case-control study in China, Int.J.Cancer 47 [4], Seite 504-509. URL: PM:1995481 [88] Chou, P. (1991): Review on risk factors of cervical cancer, Zhonghua Yi.Xue.Za Zhi.(Taipei) 48 [2], Seite 81-88. URL: PM:1654190 [89] Hingley-Wilson, S. M.; Sambandamurthy, V. K. und Jacobs, W. R., Jr. (2003): Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis, Nat.Immunol. 4 [10], Seite 949-955. URL: PM:14515128 [90] Perez, E.; Samper, S.; Bordas, Y.; Guilhot, C.; Gicquel, B. und Martin, C. (2001): An essential role for phoP in Mycobacterium tuberculosis virulence, Mol.Microbiol. 41 [1], Seite 179-187. URL: PM:11454210 [91] Braunstein, M.; Espinosa, B. J.; Chan, J.; Belisle, J. T. und Jacobs, R. (2003): SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis, Mol.Microbiol. 48 [2], Seite 453-464. URL: PM:12675804 [92] Tullius, M. V.; Harth, G. und Horwitz, M. A. (2003): Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs, Infect.Immun. 71 [7], Seite 3927-3936. URL: PM:12819079 [93] Sambandamurthy, V. K.; Wang, X.; Chen, B.; Russell, R. G.; Derrick, S.; Collins, F. M.; Morris, S. L. und Jacobs, W. R., Jr. (2002): A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis, Nat.Med. 8 [10], Seite 1171-1174. URL: PM:12219086 [94] Mendonca-Lima, L.; Picardeau, M.; Raynaud, C.; Rauzier, J.; de la Salmoniere, Y. O.; Barker, L.; Bigi, F.; Cataldi, A.; Gicquel, B. und Reyrat, J. M. (2001): Erp, an extracellular protein family specific to mycobacteria, Microbiology 147 [Pt 8], Seite 2315-2320. URL: PM:11496008 [95] Berthet, F. X.; Lagranderie, M.; Gounon, P.; Laurent-Winter, C.; Ensergueix, D.; Chavarot, P.; Thouron, F.; Maranghi, E.; Pelicic, V.; Portnoi, D.; Marchal, G. und Gicquel, B. (1998): Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene, Science 282 [5389], Seite 759-762. URL: PM:9784137 [96] Yuan, Y.; Crane, D. D.; Simpson, R. M.; Zhu, Y. Q.; Hickey, M. J.; Sherman, D. R. und Barry, C. E., III (1998): The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages, Proc.Natl.Acad.Sci.U.S.A 95 [16], Seite 9578-9583. URL: PM:9689123 [97] MacMicking, J.; Xie, Q. W. und Nathan, C. (1997): Nitric oxide and macrophage function, Annu.Rev.Immunol. 15, Seite 323-350. URL: PM:9143691 [98] Miller, R. A. und Britigan, B. E. (1997): Role of oxidants in microbial pathophysiology, Clin.Microbiol.Rev. 10 [1], Seite 1-18. URL: PM:8993856 [99] Weiss, S. J. (1986): Oxygen, ischemia and inflammation, Acta Physiol Scand.Suppl 548, Seite 9-37. URL: PM:3019082 [100] Moncada, S. und Higgs, A. (1993): The L-arginine-nitric oxide pathway, N.Engl.J.Med. 329 [27], Seite 2002-2012. URL: PM:7504210 [101] Collins, H. L. und Kaufmann, S. H. (2001): Prospects for better tuberculosis vaccines, Lancet Infect.Dis. 1 [1], Seite 21-28. URL: PM:11871406 [102] Murray, P. J.; Aldovini, A. und Young, R. A. (1996): Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines, Proc.Natl.Acad.Sci.U.S.A 93 [2], Seite 934-939. URL: PM:8570663 [103] Hess, J.; Miko, D.; Catic, A.; Lehmensiek, V.; Russell, D. G. und Kaufmann, S. H. (1998): Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes, Proc.Natl.Acad.Sci.U.S.A 95 [9], Seite 5299-5304. URL: PM:9560270 [104] Horwitz, M. A.; Harth, G.; Dillon, B. J. und Maslesa-Galic', S. (2000): Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model, Proc.Natl.Acad.Sci.U.S.A 97 [25], Seite 13853-13858. URL: PM:11095745